Request Free Sample PDFVaginal Antifungals Market Size, Share, Growth, and Industry Analysis, By Type (Polyenes, Azoles, Allylamines, Echinocandins, Others), By Application (Hospital Pharmacies, Supermarkets/hypermarkets, Online Pharmacies, Gynaecology Clinics, Others), Regional Insights and Forecast to 2035
Buy Now
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Vaginal Antifungals Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Vaginal Antifungals Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Vaginal Antifungals Business Mode and Production Process
2.3.1 Vaginal Antifungals Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Vaginal Antifungals Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Vaginal Antifungals
2.4.2 Raw Material Cost of Vaginal Antifungals
2.4.3 Labor Cost of Vaginal Antifungals
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global Vaginal Antifungals Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Vaginal Antifungals Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Vaginal Antifungals Price by Manufacturer (2021-2026)
4.4 Vaginal Antifungals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Vaginal Antifungals, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Vaginal Antifungals, Product Offered and Application
4.7 Vaginal Antifungals Market Competitive Situation and Trends
4.7.1 Vaginal Antifungals Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Vaginal Antifungals Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global Vaginal Antifungals Market Historical Development by Geographic Region (2021-2026)
5.1 Global Vaginal Antifungals Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Vaginal Antifungals Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Vaginal Antifungals Market Status by Country (2021-2026)
5.3.1 North America Vaginal Antifungals Sales Volume by Country (2021-2026)
5.3.2 North America Vaginal Antifungals Revenue by Country (2021-2026)
5.3.3 United States Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Vaginal Antifungals Market Status by Country (2021-2026)
5.4.1 Europe Vaginal Antifungals Sales Volume by Country (2021-2026)
5.4.2 Europe Vaginal Antifungals Revenue by Country (2021-2026)
5.4.3 Germany Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Vaginal Antifungals Market Status by Country (2021-2026)
5.5.1 Asia Pacific Vaginal Antifungals Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Vaginal Antifungals Revenue by Country (2021-2026)
5.5.3 China Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Vaginal Antifungals Market Status by Country (2021-2026)
5.6.1 Latin America Vaginal Antifungals Sales Volume by Country (2021-2026)
5.6.2 Latin America Vaginal Antifungals Revenue by Country (2021-2026)
5.6.3 Mexico Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Vaginal Antifungals Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Vaginal Antifungals Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Vaginal Antifungals Revenue by Country (2021-2026)
5.7.3 GCC Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
6 Global Vaginal Antifungals Market Historical Development by Product Type (2021-2026)
6.1 Vaginal Antifungals Definition by Type
6.2 Global Vaginal Antifungals Historical Sales Volume by Product Type (2021-2026)
6.3 Global Vaginal Antifungals Historical Revenue by Product Type (2021-2026)
6.4 Global Vaginal Antifungals Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Polyenes (2021-2026)
6.5.2 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Azoles (2021-2026)
6.5.3 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Allylamines (2021-2026)
6.5.4 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Echinocandins (2021-2026)
6.5.5 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)
7 Global Vaginal Antifungals Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Vaginal Antifungals Historical Sales Volume by End User (2021-2026)
7.3 Global Vaginal Antifungals Historical Revenue by End User (2021-2026)
7.4 Global Vaginal Antifungals Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Hospital Pharmacies (2021-2026)
7.5.2 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Supermarkets/hypermarkets (2021-2026)
7.5.3 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Online Pharmacies (2021-2026)
7.5.4 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Gynaecology Clinics (2021-2026)
7.5.5 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)
8 Leading Companies Profiles
8.1 SCYNEXIS, Inc.
8.1.1 SCYNEXIS, Inc. Corporation Information
8.1.2 SCYNEXIS, Inc. - Vaginal Antifungals Product Portfolio and Specification
8.1.3 SCYNEXIS, Inc. Performance Analysis (2021-2026)
8.1.4 SCYNEXIS, Inc. Business and Markets Served
8.1.5 SCYNEXIS, Inc. Recent Developments
8.2 Grupo Ferrer Internacional, S.A.
8.2.1 Grupo Ferrer Internacional, S.A. Corporation Information
8.2.2 Grupo Ferrer Internacional, S.A. - Vaginal Antifungals Product Portfolio and Specification
8.2.3 Grupo Ferrer Internacional, S.A. Performance Analysis (2021-2026)
8.2.4 Grupo Ferrer Internacional, S.A. Business and Markets Served
8.2.5 Grupo Ferrer Internacional, S.A. Recent Developments
8.3 Bausch Health Companies Inc
8.3.1 Bausch Health Companies Inc Corporation Information
8.3.2 Bausch Health Companies Inc - Vaginal Antifungals Product Portfolio and Specification
8.3.3 Bausch Health Companies Inc Performance Analysis (2021-2026)
8.3.4 Bausch Health Companies Inc Business and Markets Served
8.3.5 Bausch Health Companies Inc Recent Developments
8.4 Astellas Pharma Inc.
8.4.1 Astellas Pharma Inc. Corporation Information
8.4.2 Astellas Pharma Inc. - Vaginal Antifungals Product Portfolio and Specification
8.4.3 Astellas Pharma Inc. Performance Analysis (2021-2026)
8.4.4 Astellas Pharma Inc. Business and Markets Served
8.4.5 Astellas Pharma Inc. Recent Developments
8.5 NovaDigm Therapeutics, Inc.
8.5.1 NovaDigm Therapeutics, Inc. Corporation Information
8.5.2 NovaDigm Therapeutics, Inc. - Vaginal Antifungals Product Portfolio and Specification
8.5.3 NovaDigm Therapeutics, Inc. Performance Analysis (2021-2026)
8.5.4 NovaDigm Therapeutics, Inc. Business and Markets Served
8.5.5 NovaDigm Therapeutics, Inc. Recent Developments
8.6 Mycovia Pharmaceuticals, Inc.
8.6.1 Mycovia Pharmaceuticals, Inc. Corporation Information
8.6.2 Mycovia Pharmaceuticals, Inc. - Vaginal Antifungals Product Portfolio and Specification
8.6.3 Mycovia Pharmaceuticals, Inc. Performance Analysis (2021-2026)
8.6.4 Mycovia Pharmaceuticals, Inc. Business and Markets Served
8.6.5 Mycovia Pharmaceuticals, Inc. Recent Developments
8.7 Cidara Therapeutics, Inc.
8.7.1 Cidara Therapeutics, Inc. Corporation Information
8.7.2 Cidara Therapeutics, Inc. - Vaginal Antifungals Product Portfolio and Specification
8.7.3 Cidara Therapeutics, Inc. Performance Analysis (2021-2026)
8.7.4 Cidara Therapeutics, Inc. Business and Markets Served
8.7.5 Cidara Therapeutics, Inc. Recent Developments
8.8 ANI Pharmaceuticals, Inc.
8.8.1 ANI Pharmaceuticals, Inc. Corporation Information
8.8.2 ANI Pharmaceuticals, Inc. - Vaginal Antifungals Product Portfolio and Specification
8.8.3 ANI Pharmaceuticals, Inc. Performance Analysis (2021-2026)
8.8.4 ANI Pharmaceuticals, Inc. Business and Markets Served
8.8.5 ANI Pharmaceuticals, Inc. Recent Developments
8.9 Pfizer Inc.
8.9.1 Pfizer Inc. Corporation Information
8.9.2 Pfizer Inc. - Vaginal Antifungals Product Portfolio and Specification
8.9.3 Pfizer Inc. Performance Analysis (2021-2026)
8.9.4 Pfizer Inc. Business and Markets Served
8.9.5 Pfizer Inc. Recent Developments
8.10 GSK plc.
8.10.1 GSK plc. Corporation Information
8.10.2 GSK plc. - Vaginal Antifungals Product Portfolio and Specification
8.10.3 GSK plc. Performance Analysis (2021-2026)
8.10.4 GSK plc. Business and Markets Served
8.10.5 GSK plc. Recent Developments
8.11 Hikma Pharmaceuticals Plc
8.11.1 Hikma Pharmaceuticals Plc Corporation Information
8.11.2 Hikma Pharmaceuticals Plc - Vaginal Antifungals Product Portfolio and Specification
8.11.3 Hikma Pharmaceuticals Plc Performance Analysis (2021-2026)
8.11.4 Hikma Pharmaceuticals Plc Business and Markets Served
8.11.5 Hikma Pharmaceuticals Plc Recent Developments
8.12 Aurobindo Pharma Limited
8.12.1 Aurobindo Pharma Limited Corporation Information
8.12.2 Aurobindo Pharma Limited - Vaginal Antifungals Product Portfolio and Specification
8.12.3 Aurobindo Pharma Limited Performance Analysis (2021-2026)
8.12.4 Aurobindo Pharma Limited Business and Markets Served
8.12.5 Aurobindo Pharma Limited Recent Developments
8.13 Basilea Pharmaceutica Ltd.
8.13.1 Basilea Pharmaceutica Ltd. Corporation Information
8.13.2 Basilea Pharmaceutica Ltd. - Vaginal Antifungals Product Portfolio and Specification
8.13.3 Basilea Pharmaceutica Ltd. Performance Analysis (2021-2026)
8.13.4 Basilea Pharmaceutica Ltd. Business and Markets Served
8.13.5 Basilea Pharmaceutica Ltd. Recent Developments
8.14 Glenmark Pharmaceuticals Limited
8.14.1 Glenmark Pharmaceuticals Limited Corporation Information
8.14.2 Glenmark Pharmaceuticals Limited - Vaginal Antifungals Product Portfolio and Specification
8.14.3 Glenmark Pharmaceuticals Limited Performance Analysis (2021-2026)
8.14.4 Glenmark Pharmaceuticals Limited Business and Markets Served
8.14.5 Glenmark Pharmaceuticals Limited Recent Developments
8.15 Lupin Limited
8.15.1 Lupin Limited Corporation Information
8.15.2 Lupin Limited - Vaginal Antifungals Product Portfolio and Specification
8.15.3 Lupin Limited Performance Analysis (2021-2026)
8.15.4 Lupin Limited Business and Markets Served
8.15.5 Lupin Limited Recent Developments
8.16 Amplyx Pharmaceuticals Inc.
8.16.1 Amplyx Pharmaceuticals Inc. Corporation Information
8.16.2 Amplyx Pharmaceuticals Inc. - Vaginal Antifungals Product Portfolio and Specification
8.16.3 Amplyx Pharmaceuticals Inc. Performance Analysis (2021-2026)
8.16.4 Amplyx Pharmaceuticals Inc. Business and Markets Served
8.16.5 Amplyx Pharmaceuticals Inc. Recent Developments
8.17 Dr. Reddy's Laboratories
8.17.1 Dr. Reddy's Laboratories Corporation Information
8.17.2 Dr. Reddy's Laboratories - Vaginal Antifungals Product Portfolio and Specification
8.17.3 Dr. Reddy's Laboratories Performance Analysis (2021-2026)
8.17.4 Dr. Reddy's Laboratories Business and Markets Served
8.17.5 Dr. Reddy's Laboratories Recent Developments
8.18 Pacgen Life Science Corporation
8.18.1 Pacgen Life Science Corporation Corporation Information
8.18.2 Pacgen Life Science Corporation - Vaginal Antifungals Product Portfolio and Specification
8.18.3 Pacgen Life Science Corporation Performance Analysis (2021-2026)
8.18.4 Pacgen Life Science Corporation Business and Markets Served
8.18.5 Pacgen Life Science Corporation Recent Developments
9 Global Vaginal Antifungals Market Forecast by Product Type and End User (2026-2034)
9.1 Global Vaginal Antifungals Market Forecast by Product Type (2026-2034)
9.1.1 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Polyenes (2026-2034)
9.1.2 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Azoles (2026-2034)
9.1.3 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Allylamines (2026-2034)
9.1.4 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Echinocandins (2026-2034)
9.1.5 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)
9.2 Global Vaginal Antifungals Market Forecast by End User (2026-2034)
9.2.1 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Hospital Pharmacies (2026-2034)
9.2.2 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Supermarkets/hypermarkets (2026-2034)
9.2.3 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Online Pharmacies (2026-2034)
9.2.4 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Gynaecology Clinics (2026-2034)
9.2.5 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)
10 Global Vaginal Antifungals Market Forecast by Geographic Region (2026-2034)
10.1 Global Vaginal Antifungals Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Vaginal Antifungals Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Vaginal Antifungals Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Vaginal Antifungals Business Mode and Production Process
2.3.1 Vaginal Antifungals Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Vaginal Antifungals Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Vaginal Antifungals
2.4.2 Raw Material Cost of Vaginal Antifungals
2.4.3 Labor Cost of Vaginal Antifungals
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global Vaginal Antifungals Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Vaginal Antifungals Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Vaginal Antifungals Price by Manufacturer (2021-2026)
4.4 Vaginal Antifungals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Vaginal Antifungals, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Vaginal Antifungals, Product Offered and Application
4.7 Vaginal Antifungals Market Competitive Situation and Trends
4.7.1 Vaginal Antifungals Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Vaginal Antifungals Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global Vaginal Antifungals Market Historical Development by Geographic Region (2021-2026)
5.1 Global Vaginal Antifungals Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Vaginal Antifungals Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Vaginal Antifungals Market Status by Country (2021-2026)
5.3.1 North America Vaginal Antifungals Sales Volume by Country (2021-2026)
5.3.2 North America Vaginal Antifungals Revenue by Country (2021-2026)
5.3.3 United States Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Vaginal Antifungals Market Status by Country (2021-2026)
5.4.1 Europe Vaginal Antifungals Sales Volume by Country (2021-2026)
5.4.2 Europe Vaginal Antifungals Revenue by Country (2021-2026)
5.4.3 Germany Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Vaginal Antifungals Market Status by Country (2021-2026)
5.5.1 Asia Pacific Vaginal Antifungals Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Vaginal Antifungals Revenue by Country (2021-2026)
5.5.3 China Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Vaginal Antifungals Market Status by Country (2021-2026)
5.6.1 Latin America Vaginal Antifungals Sales Volume by Country (2021-2026)
5.6.2 Latin America Vaginal Antifungals Revenue by Country (2021-2026)
5.6.3 Mexico Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Vaginal Antifungals Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Vaginal Antifungals Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Vaginal Antifungals Revenue by Country (2021-2026)
5.7.3 GCC Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Vaginal Antifungals Sales Volume, Revenue and Growth (2021-2026)
6 Global Vaginal Antifungals Market Historical Development by Product Type (2021-2026)
6.1 Vaginal Antifungals Definition by Type
6.2 Global Vaginal Antifungals Historical Sales Volume by Product Type (2021-2026)
6.3 Global Vaginal Antifungals Historical Revenue by Product Type (2021-2026)
6.4 Global Vaginal Antifungals Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Polyenes (2021-2026)
6.5.2 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Azoles (2021-2026)
6.5.3 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Allylamines (2021-2026)
6.5.4 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Echinocandins (2021-2026)
6.5.5 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)
7 Global Vaginal Antifungals Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Vaginal Antifungals Historical Sales Volume by End User (2021-2026)
7.3 Global Vaginal Antifungals Historical Revenue by End User (2021-2026)
7.4 Global Vaginal Antifungals Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Hospital Pharmacies (2021-2026)
7.5.2 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Supermarkets/hypermarkets (2021-2026)
7.5.3 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Online Pharmacies (2021-2026)
7.5.4 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Gynaecology Clinics (2021-2026)
7.5.5 Global Vaginal Antifungals Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)
8 Leading Companies Profiles
8.1 SCYNEXIS, Inc.
8.1.1 SCYNEXIS, Inc. Corporation Information
8.1.2 SCYNEXIS, Inc. - Vaginal Antifungals Product Portfolio and Specification
8.1.3 SCYNEXIS, Inc. Performance Analysis (2021-2026)
8.1.4 SCYNEXIS, Inc. Business and Markets Served
8.1.5 SCYNEXIS, Inc. Recent Developments
8.2 Grupo Ferrer Internacional, S.A.
8.2.1 Grupo Ferrer Internacional, S.A. Corporation Information
8.2.2 Grupo Ferrer Internacional, S.A. - Vaginal Antifungals Product Portfolio and Specification
8.2.3 Grupo Ferrer Internacional, S.A. Performance Analysis (2021-2026)
8.2.4 Grupo Ferrer Internacional, S.A. Business and Markets Served
8.2.5 Grupo Ferrer Internacional, S.A. Recent Developments
8.3 Bausch Health Companies Inc
8.3.1 Bausch Health Companies Inc Corporation Information
8.3.2 Bausch Health Companies Inc - Vaginal Antifungals Product Portfolio and Specification
8.3.3 Bausch Health Companies Inc Performance Analysis (2021-2026)
8.3.4 Bausch Health Companies Inc Business and Markets Served
8.3.5 Bausch Health Companies Inc Recent Developments
8.4 Astellas Pharma Inc.
8.4.1 Astellas Pharma Inc. Corporation Information
8.4.2 Astellas Pharma Inc. - Vaginal Antifungals Product Portfolio and Specification
8.4.3 Astellas Pharma Inc. Performance Analysis (2021-2026)
8.4.4 Astellas Pharma Inc. Business and Markets Served
8.4.5 Astellas Pharma Inc. Recent Developments
8.5 NovaDigm Therapeutics, Inc.
8.5.1 NovaDigm Therapeutics, Inc. Corporation Information
8.5.2 NovaDigm Therapeutics, Inc. - Vaginal Antifungals Product Portfolio and Specification
8.5.3 NovaDigm Therapeutics, Inc. Performance Analysis (2021-2026)
8.5.4 NovaDigm Therapeutics, Inc. Business and Markets Served
8.5.5 NovaDigm Therapeutics, Inc. Recent Developments
8.6 Mycovia Pharmaceuticals, Inc.
8.6.1 Mycovia Pharmaceuticals, Inc. Corporation Information
8.6.2 Mycovia Pharmaceuticals, Inc. - Vaginal Antifungals Product Portfolio and Specification
8.6.3 Mycovia Pharmaceuticals, Inc. Performance Analysis (2021-2026)
8.6.4 Mycovia Pharmaceuticals, Inc. Business and Markets Served
8.6.5 Mycovia Pharmaceuticals, Inc. Recent Developments
8.7 Cidara Therapeutics, Inc.
8.7.1 Cidara Therapeutics, Inc. Corporation Information
8.7.2 Cidara Therapeutics, Inc. - Vaginal Antifungals Product Portfolio and Specification
8.7.3 Cidara Therapeutics, Inc. Performance Analysis (2021-2026)
8.7.4 Cidara Therapeutics, Inc. Business and Markets Served
8.7.5 Cidara Therapeutics, Inc. Recent Developments
8.8 ANI Pharmaceuticals, Inc.
8.8.1 ANI Pharmaceuticals, Inc. Corporation Information
8.8.2 ANI Pharmaceuticals, Inc. - Vaginal Antifungals Product Portfolio and Specification
8.8.3 ANI Pharmaceuticals, Inc. Performance Analysis (2021-2026)
8.8.4 ANI Pharmaceuticals, Inc. Business and Markets Served
8.8.5 ANI Pharmaceuticals, Inc. Recent Developments
8.9 Pfizer Inc.
8.9.1 Pfizer Inc. Corporation Information
8.9.2 Pfizer Inc. - Vaginal Antifungals Product Portfolio and Specification
8.9.3 Pfizer Inc. Performance Analysis (2021-2026)
8.9.4 Pfizer Inc. Business and Markets Served
8.9.5 Pfizer Inc. Recent Developments
8.10 GSK plc.
8.10.1 GSK plc. Corporation Information
8.10.2 GSK plc. - Vaginal Antifungals Product Portfolio and Specification
8.10.3 GSK plc. Performance Analysis (2021-2026)
8.10.4 GSK plc. Business and Markets Served
8.10.5 GSK plc. Recent Developments
8.11 Hikma Pharmaceuticals Plc
8.11.1 Hikma Pharmaceuticals Plc Corporation Information
8.11.2 Hikma Pharmaceuticals Plc - Vaginal Antifungals Product Portfolio and Specification
8.11.3 Hikma Pharmaceuticals Plc Performance Analysis (2021-2026)
8.11.4 Hikma Pharmaceuticals Plc Business and Markets Served
8.11.5 Hikma Pharmaceuticals Plc Recent Developments
8.12 Aurobindo Pharma Limited
8.12.1 Aurobindo Pharma Limited Corporation Information
8.12.2 Aurobindo Pharma Limited - Vaginal Antifungals Product Portfolio and Specification
8.12.3 Aurobindo Pharma Limited Performance Analysis (2021-2026)
8.12.4 Aurobindo Pharma Limited Business and Markets Served
8.12.5 Aurobindo Pharma Limited Recent Developments
8.13 Basilea Pharmaceutica Ltd.
8.13.1 Basilea Pharmaceutica Ltd. Corporation Information
8.13.2 Basilea Pharmaceutica Ltd. - Vaginal Antifungals Product Portfolio and Specification
8.13.3 Basilea Pharmaceutica Ltd. Performance Analysis (2021-2026)
8.13.4 Basilea Pharmaceutica Ltd. Business and Markets Served
8.13.5 Basilea Pharmaceutica Ltd. Recent Developments
8.14 Glenmark Pharmaceuticals Limited
8.14.1 Glenmark Pharmaceuticals Limited Corporation Information
8.14.2 Glenmark Pharmaceuticals Limited - Vaginal Antifungals Product Portfolio and Specification
8.14.3 Glenmark Pharmaceuticals Limited Performance Analysis (2021-2026)
8.14.4 Glenmark Pharmaceuticals Limited Business and Markets Served
8.14.5 Glenmark Pharmaceuticals Limited Recent Developments
8.15 Lupin Limited
8.15.1 Lupin Limited Corporation Information
8.15.2 Lupin Limited - Vaginal Antifungals Product Portfolio and Specification
8.15.3 Lupin Limited Performance Analysis (2021-2026)
8.15.4 Lupin Limited Business and Markets Served
8.15.5 Lupin Limited Recent Developments
8.16 Amplyx Pharmaceuticals Inc.
8.16.1 Amplyx Pharmaceuticals Inc. Corporation Information
8.16.2 Amplyx Pharmaceuticals Inc. - Vaginal Antifungals Product Portfolio and Specification
8.16.3 Amplyx Pharmaceuticals Inc. Performance Analysis (2021-2026)
8.16.4 Amplyx Pharmaceuticals Inc. Business and Markets Served
8.16.5 Amplyx Pharmaceuticals Inc. Recent Developments
8.17 Dr. Reddy's Laboratories
8.17.1 Dr. Reddy's Laboratories Corporation Information
8.17.2 Dr. Reddy's Laboratories - Vaginal Antifungals Product Portfolio and Specification
8.17.3 Dr. Reddy's Laboratories Performance Analysis (2021-2026)
8.17.4 Dr. Reddy's Laboratories Business and Markets Served
8.17.5 Dr. Reddy's Laboratories Recent Developments
8.18 Pacgen Life Science Corporation
8.18.1 Pacgen Life Science Corporation Corporation Information
8.18.2 Pacgen Life Science Corporation - Vaginal Antifungals Product Portfolio and Specification
8.18.3 Pacgen Life Science Corporation Performance Analysis (2021-2026)
8.18.4 Pacgen Life Science Corporation Business and Markets Served
8.18.5 Pacgen Life Science Corporation Recent Developments
9 Global Vaginal Antifungals Market Forecast by Product Type and End User (2026-2034)
9.1 Global Vaginal Antifungals Market Forecast by Product Type (2026-2034)
9.1.1 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Polyenes (2026-2034)
9.1.2 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Azoles (2026-2034)
9.1.3 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Allylamines (2026-2034)
9.1.4 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Echinocandins (2026-2034)
9.1.5 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)
9.2 Global Vaginal Antifungals Market Forecast by End User (2026-2034)
9.2.1 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Hospital Pharmacies (2026-2034)
9.2.2 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Supermarkets/hypermarkets (2026-2034)
9.2.3 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Online Pharmacies (2026-2034)
9.2.4 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Gynaecology Clinics (2026-2034)
9.2.5 Global Vaginal Antifungals Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)
10 Global Vaginal Antifungals Market Forecast by Geographic Region (2026-2034)
10.1 Global Vaginal Antifungals Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Vaginal Antifungals Sales Volume, Revenue Forecast and Growth (2026-2034)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer
